Sponsors: []Modifications: that engagesin UtahThis bill takes effect on July 1, 2014.Full text:



Utah State Legislature












Legislators

By Session (1896-Current)
Alphabetical (Historical)
Find by Address/Map
More


Bills

Bills/Bill Requests
Passed Bills
2017 Bills

Keyword Search
Reading Calendars
Tracking Service
More


Committees

All Committees
Appropriations
Commissions

Independent Legislative Ethics Commission
Interim
Standing
Subcommittees
Task Forces
Bills In Committees


Utah Code / Constitution


Title/Chapter/Section
Keyword Search 

Utah Constitution
Laws of Utah 1851-ongoing
Utah Territorial Laws 
More


Senate

Main Page 
About The Senate 
Leadership 
Roster 
Seating Chart 
District Maps 
Extraordinary Sessions 
Reading Calendars 
Past Floor Debates 
Senate Journals 


House

Main Page
About the House 
Leadership 
Roster 
Seating Chart 
District Maps 
Reading Calendars 
Past Floor Debates 
Journals 
Conflict of Interest Forms 


Legislative Guide 

Legislative Guide
Civic Programs
GRAMA (Records Requests)


Publications

Search Publications
Appropriations
Audits
Bagels & Briefings
Briefing Papers
Digest of Legislation
Legislative Drafting Manual

Journals

Interim Highlights

Legislative Rules
GRAMA (Records Requests)
Public Email
State Organization Charts
YouTube Channel
Requests for Proposals and Legal Notices
More


Legislative Histories

Legislative History Resources
How to Research
Bill Drafting/Research Files (1990-Ongoing)

Working Bills (1896-1989)
Interim Committee Histories (1990-Ongoing) 
Journals
Past House Floor Debates
Past Senate Floor Debates
More


Staff Offices

All Legislative Offices
Auditor General
Fiscal Analyst
Printing
Research and General Counsel
Staff Awards
Job Opportunities
More


Links of Interest

Utah Administrative Rules
Courts
Utah State Capitol
State of Utah
Federal Legislation
More






 

H.B. 114





            
1

    
 MAIL-ORDER WHOLESALE DRUG AMENDMENTS



            
2

    
2014 GENERAL SESSION

            
3

    
STATE OF UTAH

            
4

    


 Chief Sponsor:  Stewart Barlow



            
5

    



Senate Sponsor: 






  Evan J. Vickers





            
6

    

            
7

    
 LONG TITLE
            
8

    
 General Description:
            
9

    
    This bill amends the Pharmacy Practice Act.
            
10

    
 Highlighted Provisions:
            
11

    
    This bill:
            
12

    
    .    amends the definition of a class C pharmacy subject to regulation under the
            
13

    
Pharmacy Practice Act.
            
14

    
 Money Appropriated in this Bill:
            
15

    
    None
            
16

    
 Other Special Clauses:
            
17

    
    This bill takes effect on July 1, 2014.
            
18

    
 Utah Code Sections Affected:
            
19

    
AMENDS:
            
20

    
     
58-17b-102
, as last amended by Laws of Utah 2013, Chapters 52, 166, and 423
            
21

    

            
22

    
Be it enacted by the Legislature of the state of Utah:
            
23

    
    Section 1.  
Section  
58-17b-102

 is amended to read:
            
24

    
     58-17b-102.  Definitions.
            
25

    
    In addition to the definitions in Section 

58-1-102


, as used in this chapter:
            
26

    
    (1)  "Administering" means:
            
27

    
    (a)  the direct application of a prescription drug or device, whether by injection,

            
28


    
inhalation, ingestion, or by any other means, to the body of a human patient or research subject
            
29

    
by another person; or
            
30

    
    (b)  the placement by a veterinarian with the owner or caretaker of an animal or group
            
31

    
of animals of a prescription drug for the purpose of injection, inhalation, ingestion, or any other
            
32

    
means directed to the body of the animal by the owner or caretaker in accordance with written
            
33

    
or verbal directions of the veterinarian.
            
34

    
    (2)  "Adulterated drug or device" means a drug or device considered adulterated under
            
35

    
21 U.S.C.S. Sec. 351 (2003).
            
36

    
    (3) (a)  "Analytical laboratory" means a facility in possession of prescription drugs for
            
37

    
the purpose of analysis.
            
38

    
    (b)  "Analytical laboratory" does not include a laboratory possessing prescription drugs
            
39

    
used as standards and controls in performing drug monitoring or drug screening analysis if the
            
40

    
prescription drugs are prediluted in a human or animal body fluid, human or animal body fluid
            
41

    
components, organic solvents, or inorganic buffers at a concentration not exceeding one
            
42

    
milligram per milliliter when labeled or otherwise designated as being for in vitro diagnostic
            
43

    
use.
            
44

    
    (4)  "Animal euthanasia agency" means an agency performing euthanasia on animals by
            
45

    
the use of prescription drugs.
            
46

    
    (5)  "Automated pharmacy systems" includes mechanical systems which perform
            
47

    
operations or activities, other than compounding or administration, relative to the storage,
            
48

    
packaging, dispensing, or distribution of medications, and which collect, control, and maintain
            
49

    
all transaction information.
            
50

    
    (6)  "Beyond use date" means the date determined by a pharmacist and placed on a
            
51

    
prescription label at the time of dispensing that indicates to the patient or caregiver a time
            
52

    
beyond which the contents of the prescription are not recommended to be used.
            
53

    
    (7)  "Board of pharmacy" or "board" means the Utah State Board of Pharmacy created
            
54

    
in Section 

58-17b-201


.
            
55

    
    (8)  "Branch pharmacy" means a pharmacy or other facility in a rural or medically
            
56

    
underserved area, used for the storage and dispensing of prescription drugs, which is dependent
            
57

    
upon, stocked by, and supervised by a pharmacist in another licensed pharmacy designated and
            
58

    
approved by the division as the parent pharmacy.

            
59


    
    (9)  "Centralized prescription processing" means the processing by a pharmacy of a
            
60

    
request from another pharmacy to fill or refill a prescription drug order or to perform
            
61

    
processing functions such as dispensing, drug utilization review, claims adjudication, refill
            
62

    
authorizations, and therapeutic interventions.
            
63

    
    (10)  "Class A pharmacy" means a pharmacy located in Utah that is authorized as a
            
64

    
retail pharmacy to compound or dispense a drug or dispense a device to the public under a
            
65

    
prescription order.
            
66

    
    (11)  "Class B pharmacy":
            
67

    
    (a)  means a pharmacy located in Utah:
            
68

    
    (i)  that is authorized to provide pharmaceutical care for patients in an institutional
            
69

    
setting; and
            
70

    
    (ii)  whose primary purpose is to provide a physical environment for patients to obtain
            
71

    
health care services; and
            
72

    
    (b) (i)  includes closed-door, hospital, clinic, nuclear, and branch pharmacies; and
            
73

    
    (ii)  pharmaceutical administration and sterile product preparation facilities.
            
74

    
    (12)  "Class C pharmacy" means a pharmacy [located in Utah that is authorized to
            
75

    
engage] that engages in the manufacture, production, wholesale, or distribution of drugs or
            
76

    
devices in Utah.
            
77

    
    (13)  "Class D pharmacy" means a nonresident pharmacy.
            
78

    
    (14)  "Class E pharmacy" means all other pharmacies.
            
79

    
    (15)  "Closed-door pharmacy" means a pharmacy that provides pharmaceutical care to a
            
80

    
defined and exclusive group of patients who have access to the services of the pharmacy
            
81

    
because they are treated by or have an affiliation with a specific entity, including a health
            
82

    
maintenance organization or an infusion company, but not including a hospital pharmacy, a
            
83

    
retailer of goods to the general public, or the office of a practitioner.
            
84

    
    (16)  "Collaborative pharmacy practice" means a practice of pharmacy whereby one or
            
85

    
more pharmacists have jointly agreed, on a voluntary basis, to work in conjunction with one or
            
86

    
more practitioners under protocol whereby the pharmacist may perform certain pharmaceutical
            
87

    
care functions authorized by the practitioner or practitioners under certain specified conditions
            
88

    
or limitations.
            
89

    
    (17)  "Collaborative pharmacy practice agreement" means a written and signed

            
90


    
agreement between one or more pharmacists and one or more practitioners that provides for
            
91

    
collaborative pharmacy practice for the purpose of drug therapy management of patients and
            
92

    
prevention of disease of human subjects.
            
93

    
    (18) (a)  "Compounding" means the preparation, mixing, assembling, packaging, or
            
94

    
labeling of a limited quantity drug, sterile product, or device:
            
95

    
    (i)  as the result of a practitioner's prescription order or initiative based on the
            
96

    
practitioner, patient, or pharmacist relationship in the course of professional practice;
            
97

    
    (ii)  for the purpose of, or as an incident to, research, teaching, or chemical analysis and
            
98

    
not for sale or dispensing; or
            
99

    
    (iii)  in anticipation of prescription drug orders based on routine, regularly observed
            
100

    
prescribing patterns.
            
101

    
    (b)  "Compounding" does not include:
            
102

    
    (i)  the preparation of prescription drugs by a pharmacist or pharmacy intern for sale to
            
103

    
another pharmacist or pharmaceutical facility;
            
104

    
    (ii)  the preparation by a pharmacist or pharmacy intern of any prescription drug in a
            
105

    
dosage form which is regularly and commonly available from a manufacturer in quantities and
            
106

    
strengths prescribed by a practitioner; or
            
107

    
    (iii)  the preparation of a prescription drug, sterile product, or device which has been
            
108

    
withdrawn from the market for safety reasons.
            
109

    
    (19)  "Confidential information" has the same meaning as "protected health
            
110

    
information" under the Standards for Privacy of Individually Identifiable Health Information,
            
111

    
45 C.F.R. Parts 160 and 164.
            
112

    
    (20)  "Controlled substance" has the same definition as in Section 

58-37-2


.
            
113

    
    (21)  "Dietary supplement" has the same meaning as Public Law Title 103, Chapter
            
114

    
417, Sec. 3a(ff) which is incorporated by reference.
            
115

    
    (22)  "Dispense" means the interpretation, evaluation, and implementation of a
            
116

    
prescription drug order or device or nonprescription drug or device under a lawful order of a
            
117

    
practitioner in a suitable container appropriately labeled for subsequent administration to or use
            
118

    
by a patient, research subject, or an animal.
            
119

    
    (23)  "Distribute" means to deliver a drug or device other than by administering or
            
120

    
dispensing.

            
121


    
    (24) (a)  "Drug" means:
            
122

    
    (i)  a substance recognized in the official United States Pharmacopoeia, Official
            
123

    
Homeopathic Pharmacopoeia of the United States, or Official National Formulary, or any
            
124

    
supplement to any of them, intended for use in the diagnosis, cure, mitigation, treatment, or
            
125

    
prevention of disease in humans or animals;
            
126

    
    (ii)  a substance that is required by any applicable federal or state law or rule to be
            
127

    
dispensed by prescription only or is restricted to administration by practitioners only;
            
128

    
    (iii)  a substance other than food intended to affect the structure or any function of the
            
129

    
body of humans or other animals; and
            
130

    
    (iv)  substances intended for use as a component of any substance specified in
            
131

    
Subsections (24)(a)(i), (ii), (iii), and (iv).
            
132

    
    (b)  "Drug" does not include dietary supplements.
            
133

    
    (25)  "Drug regimen review" includes the following activities:
            
134

    
    (a)  evaluation of the prescription drug order and patient record for:
            
135

    
    (i)  known allergies;
            
136

    
    (ii)  rational therapy-contraindications;
            
137

    
    (iii)  reasonable dose and route of administration; and
            
138

    
    (iv)  reasonable directions for use;
            
139

    
    (b)  evaluation of the prescription drug order and patient record for duplication of
            
140

    
therapy;
            
141

    
    (c)  evaluation of the prescription drug order and patient record for the following
            
142

    
interactions:
            
143

    
    (i)  drug-drug;
            
144

    
    (ii)  drug-food;
            
145

    
    (iii)  drug-disease; and
            
146

    
    (iv)  adverse drug reactions; and
            
147

    
    (d)  evaluation of the prescription drug order and patient record for proper utilization,
            
148

    
including over- or under-utilization, and optimum therapeutic outcomes.
            
149

    
    (26)  "Drug sample" means a prescription drug packaged in small quantities consistent
            
150

    
with limited dosage therapy of the particular drug, which is marked "sample", is not intended to
            
151

    
be sold, and is intended to be provided to practitioners for the immediate needs of patients for

            
152


    
trial purposes or to provide the drug to the patient until a prescription can be filled by the
            
153

    
patient.
            
154

    
    (27)  "Electronic signature" means a trusted, verifiable, and secure electronic sound,
            
155

    
symbol, or process attached to or logically associated with a record and executed or adopted by
            
156

    
a person with the intent to sign the record.
            
157

    
    (28)  "Electronic transmission" means transmission of information in electronic form or
            
158

    
the transmission of the exact visual image of a document by way of electronic equipment.
            
159

    
    (29)  "Hospital pharmacy" means a pharmacy providing pharmaceutical care to
            
160

    
inpatients of a general acute hospital or specialty hospital licensed by the Department of Health
            
161

    
under Title 26, Chapter 21, Health Care Facility Licensing and Inspection Act.
            
162

    
    (30)  "Legend drug" has the same meaning as prescription drug.
            
163

    
    (31)  "Licensed pharmacy technician" means an individual licensed with the division,
            
164

    
that may, under the supervision of a pharmacist, perform the activities involved in the
            
165

    
technician practice of pharmacy.
            
166

    
    (32)  "Manufacturer" means a person or business physically located in Utah licensed to
            
167

    
be engaged in the manufacturing of drugs or devices.
            
168

    
    (33) (a)  "Manufacturing" means:
            
169

    
    (i)  the production, preparation, propagation, conversion, or processing of a drug or
            
170

    
device, either directly or indirectly, by extraction from substances of natural origin or
            
171

    
independently by means of chemical or biological synthesis, or by a combination of extraction
            
172

    
and chemical synthesis, and includes any packaging or repackaging of the substance or labeling
            
173

    
or relabeling of its container; and
            
174

    
    (ii)  the promotion and marketing of such drugs or devices.
            
175

    
    (b)  "Manufacturing" includes the preparation and promotion of commercially available
            
176

    
products from bulk compounds for resale by pharmacies, practitioners, or other persons.
            
177

    
    (c)  "Manufacturing" does not include the preparation or compounding of a drug by a
            
178

    
pharmacist, pharmacy intern, or practitioner for that individual's own use or the preparation,
            
179

    
compounding, packaging, labeling of a drug, or incident to research, teaching, or chemical
            
180

    
analysis.
            
181

    
    (34)  "Medical order" means a lawful order of a practitioner which may include a
            
182

    
prescription drug order.

            
183


    
    (35)  "Medication profile" or "profile" means a record system maintained as to drugs or
            
184

    
devices prescribed for a pharmacy patient to enable a pharmacist or pharmacy intern to analyze
            
185

    
the profile to provide pharmaceutical care.
            
186

    
    (36)  "Misbranded drug or device" means a drug or device considered misbranded under
            
187

    
21 U.S.C.S. Sec. 352 (2003).
            
188

    
    (37) (a)  "Nonprescription drug" means a drug which:
            
189

    
    (i)  may be sold without a prescription; and
            
190

    
    (ii)  is labeled for use by the consumer in accordance with federal law.
            
191

    
    (b)  "Nonprescription drug" includes homeopathic remedies.
            
192

    
    (38)  "Nonresident pharmacy" means a pharmacy located outside of Utah that sells to a
            
193

    
person in Utah.
            
194

    
    (39)  "Nuclear pharmacy" means a pharmacy providing radio-pharmaceutical service.
            
195

    
    (40)  "Out-of-state mail service pharmacy" means a pharmaceutical facility located
            
196

    
outside the state that is licensed and in good standing in another state, that:
            
197

    
    (a)  ships, mails, or delivers by any lawful means a dispensed legend drug to a patient in
            
198

    
this state pursuant to a lawfully issued prescription;
            
199

    
    (b)  provides information to a patient in this state on drugs or devices which may
            
200

    
include, but is not limited to, advice relating to therapeutic values, potential hazards, and uses;
            
201

    
or
            
202

    
    (c)  counsels pharmacy patients residing in this state concerning adverse and therapeutic
            
203

    
effects of drugs.
            
204

    
    (41)  "Patient counseling" means the written and oral communication by the pharmacist
            
205

    
or pharmacy intern of information, to the patient or caregiver, in order to ensure proper use of
            
206

    
drugs, devices, and dietary supplements.
            
207

    
    (42)  "Pharmaceutical administration facility" means a facility, agency, or institution in
            
208

    
which:
            
209

    
    (a)  prescription drugs or devices are held, stored, or are otherwise under the control of
            
210

    
the facility or agency for administration to patients of that facility or agency;
            
211

    
    (b)  prescription drugs are dispensed to the facility or agency by a licensed pharmacist
            
212

    
or pharmacy intern with whom the facility has established a prescription drug supervising
            
213

    
relationship under which the pharmacist or pharmacy intern provides counseling to the facility

            
214


    
or agency staff as required, and oversees drug control, accounting, and destruction; and
            
215

    
    (c)  prescription drugs are professionally administered in accordance with the order of a
            
216

    
practitioner by an employee or agent of the facility or agency.
            
217

    
    (43) (a)  "Pharmaceutical care" means carrying out the following in collaboration with a
            
218

    
prescribing practitioner, and in accordance with division rule:
            
219

    
    (i)  designing, implementing, and monitoring a therapeutic drug plan intended to
            
220

    
achieve favorable outcomes related to a specific patient for the purpose of curing or preventing
            
221

    
the patient's disease;
            
222

    
    (ii)  eliminating or reducing a patient's symptoms; or
            
223

    
    (iii)  arresting or slowing a disease process.
            
224

    
    (b)  "Pharmaceutical care" does not include prescribing of drugs without consent of a
            
225

    
prescribing practitioner.
            
226

    
    (44)  "Pharmaceutical facility" means a business engaged in the dispensing, delivering,
            
227

    
distributing, manufacturing, or wholesaling of prescription drugs or devices within or into this
            
228

    
state.
            
229

    
    (45) (a)  "Pharmaceutical wholesaler or distributor" means a pharmaceutical facility
            
230

    
engaged in the business of wholesale vending or selling of a prescription drug or device to
            
231

    
other than a consumer or user of the prescription drug or device that the pharmaceutical facility
            
232

    
has not produced, manufactured, compounded, or dispensed.
            
233

    
    (b)  "Pharmaceutical wholesaler or distributor" does not include a pharmaceutical
            
234

    
facility carrying out the following business activities:
            
235

    
    (i)  intracompany sales;
            
236

    
    (ii)  the sale, purchase, or trade of a prescription drug or device, or an offer to sell,
            
237

    
purchase, or trade a prescription drug or device, if the activity is carried out between one or
            
238

    
more of the following entities under common ownership or common administrative control, as
            
239

    
defined by division rule:
            
240

    
    (A)  hospitals;
            
241

    
    (B)  pharmacies;
            
242

    
    (C)  chain pharmacy warehouses, as defined by division rule; or
            
243

    
    (D)  other health care entities, as defined by division rule;
            
244

    
    (iii)  the sale, purchase, or trade of a prescription drug or device, or an offer to sell,

            
245


    
purchase, or trade a prescription drug or device, for emergency medical reasons, including
            
246

    
supplying another pharmaceutical facility with a limited quantity of a drug, if:
            
247

    
    (A)  the facility is unable to obtain the drug through a normal distribution channel in
            
248

    
sufficient time to eliminate the risk of harm to a patient that would result from a delay in
            
249

    
obtaining the drug; and
            
250

    
    (B)  the quantity of the drug does not exceed an amount reasonably required for
            
251

    
immediate dispensing to eliminate the risk of harm;
            
252

    
    (iv)  the distribution of a prescription drug or device as a sample by representatives of a
            
253

    
manufacturer; and
            
254

    
    (v)  the distribution of prescription drugs, if:
            
255

    
    (A)  the dosage units distributed during a calendar year do not exceed five percent of
            
256

    
the sum of the dosage units distributed by the facility during the calendar year and the dosage
            
257

    
units dispensed by the facility during the calendar year; and
            
258

    
    (B)  the distribution otherwise complies with 21 C.F.R. Sec. 1307.11.
            
259

    
    (46)  "Pharmacist" means an individual licensed by this state to engage in the practice
            
260

    
of pharmacy.
            
261

    
    (47)  "Pharmacist-in-charge" means a pharmacist currently licensed in good standing
            
262

    
who accepts responsibility for the operation of a pharmacy in conformance with all laws and
            
263

    
rules pertinent to the practice of pharmacy and the distribution of drugs, and who is personally
            
264

    
in full and actual charge of the pharmacy and all personnel.
            
265

    
    (48)  "Pharmacist preceptor" means a licensed pharmacist in good standing with one or
            
266

    
more years of licensed experience.  The preceptor serves as a teacher, example of professional
            
267

    
conduct, and supervisor of interns in the professional practice of pharmacy.
            
268

    
    (49)  "Pharmacy" means any place where:
            
269

    
    (a)  drugs are dispensed;
            
270

    
    (b)  pharmaceutical care is provided;
            
271

    
    (c)  drugs are processed or handled for eventual use by a patient; or
            
272

    
    (d)  drugs are used for the purpose of analysis or research.
            
273

    
    (50)  "Pharmacy benefits manager or coordinator" means a person or entity that
            
274

    
provides pharmacy benefit management services as defined in Section 

49-20-502


 on behalf of a
            
275

    
self-insured employer, insurance company, health maintenance organization, or other plan

            
276


    
sponsor, as defined by rule.
            
277

    
    (51)  "Pharmacy intern" means an individual licensed by this state to engage in practice
            
278

    
as a pharmacy intern.
            
279

    
    (52)  "Pharmacy technician training program" means an approved technician training
            
280

    
program providing education for pharmacy technicians.
            
281

    
    (53) (a)  "Practice as a licensed pharmacy technician" means engaging in practice as a
            
282

    
pharmacy technician under the general supervision of a licensed pharmacist and in accordance
            
283

    
with a scope of practice defined by division rule made in collaboration with the board.
            
284

    
    (b)  "Practice as a licensed pharmacy technician" does not include:
            
285

    
    (i)  performing a drug utilization review, prescription drug order clarification from a
            
286

    
prescriber, final review of the prescription, dispensing of the drug, or counseling a patient with
            
287

    
respect to a prescription drug;
            
288

    
    (ii)  except as permitted by rules made by the division in consultation with the board,
            
289

    
final review of a prescribed drug prepared for dispensing;
            
290

    
    (iii)  counseling regarding nonprescription drugs and dietary supplements unless
            
291

    
delegated by the supervising pharmacist; or
            
292

    
    (iv)  receiving new prescription drug orders when communicating telephonically or
            
293

    
electronically unless the original information is recorded so the pharmacist may review the
            
294

    
prescription drug order as transmitted.
            
295

    
    (54)  "Practice of pharmacy" includes the following:
            
296

    
    (a)  providing pharmaceutical care;
            
297

    
    (b)  collaborative pharmacy practice in accordance with a collaborative pharmacy
            
298

    
practice agreement;
            
299

    
    (c)  compounding, packaging, labeling, dispensing, administering, and the coincident
            
300

    
distribution of prescription drugs or devices, provided that the administration of a prescription
            
301

    
drug or device is:
            
302

    
    (i)  pursuant to a lawful order of a practitioner when one is required by law; and
            
303

    
    (ii)  in accordance with written guidelines or protocols:
            
304

    
    (A)  established by the licensed facility in which the prescription drug or device is to be
            
305

    
administered on an inpatient basis; or
            
306

    
    (B)  approved by the division, in collaboration with the board and the Physicians

            
307


    
Licensing Board, created in Section 

58-67-201


, if the prescription drug or device is to be
            
308

    
administered on an outpatient basis solely by a licensed pharmacist;
            
309

    
    (d)  participating in drug utilization review;
            
310

    
    (e)  ensuring proper and safe storage of drugs and devices;
            
311

    
    (f)  maintaining records of drugs and devices in accordance with state and federal law
            
312

    
and the standards and ethics of the profession;
            
313

    
    (g)  providing information on drugs or devices, which may include advice relating to
            
314

    
therapeutic values, potential hazards, and uses;
            
315

    
    (h)  providing drug product equivalents;
            
316

    
    (i)  supervising pharmacist's supportive personnel, pharmacy interns, and pharmacy
            
317

    
technicians;
            
318

    
    (j)  providing patient counseling, including adverse and therapeutic effects of drugs;
            
319

    
    (k)  providing emergency refills as defined by rule;
            
320

    
    (l)  telepharmacy; and
            
321

    
    (m)  formulary management intervention.
            
322

    
    (55)  "Practice of telepharmacy" means the practice of pharmacy through the use of
            
323

    
telecommunications and information technologies.
            
324

    
    (56)  "Practice of telepharmacy across state lines" means the practice of pharmacy
            
325

    
through the use of telecommunications and information technologies that occurs when the
            
326

    
patient is physically located within one jurisdiction and the pharmacist is located in another
            
327

    
jurisdiction.
            
328

    
    (57)  "Practitioner" means an individual currently licensed, registered, or otherwise
            
329

    
authorized by the appropriate jurisdiction to prescribe and administer drugs in the course of
            
330

    
professional practice.
            
331

    
    (58)  "Prescribe" means to issue a prescription:
            
332

    
    (a)  orally or in writing; or
            
333

    
    (b)  by telephone, facsimile transmission, computer, or other electronic means of
            
334

    
communication as defined by division rule.
            
335

    
    (59)  "Prescription" means an order issued:
            
336

    
    (a)  by a licensed practitioner in the course of that practitioner's professional practice or
            
337

    
by collaborative pharmacy practice agreement; and

            
338


    
    (b)  for a controlled substance or other prescription drug or device for use by a patient
            
339

    
or an animal.
            
340

    
    (60)  "Prescription device" means an instrument, apparatus, implement, machine,
            
341

    
contrivance, implant, in vitro reagent, or other similar or related article, and any component
            
342

    
part or accessory, which is required under federal or state law to be prescribed by a practitioner
            
343

    
and dispensed by or through a person or entity licensed under this chapter or exempt from
            
344

    
licensure under this chapter.
            
345

    
    (61)  "Prescription drug" means a drug that is required by federal or state law or rule to
            
346

    
be dispensed only by prescription or is restricted to administration only by practitioners.
            
347

    
    (62)  "Research using pharmaceuticals" means research:
            
348

    
    (a)  conducted in a research facility, as defined by division rule, that is associated with a
            
349

    
university or college in the state accredited by the Northwest Commission on Colleges and
            
350

    
Universities;
            
351

    
    (b)  requiring the use of a controlled substance, prescription drug, or prescription
            
352

    
device;
            
353

    
    (c)  that uses the controlled substance, prescription drug, or prescription device in
            
354

    
accordance with standard research protocols and techniques, including, if required, those
            
355

    
approved by an institutional review committee; and
            
356

    
    (d)  that includes any documentation required for the conduct of the research and the
            
357

    
handling of the controlled substance, prescription drug, or prescription device.
            
358

    
    (63)  "Retail pharmacy" means a pharmaceutical facility dispensing prescription drugs
            
359

    
and devices to the general public.
            
360

    
    (64)  "Self-audit" means an internal evaluation of a pharmacy to determine compliance
            
361

    
with this chapter.
            
362

    
    (65)  "Supervising pharmacist" means a pharmacist who is overseeing the operation of
            
363

    
the pharmacy during a given day or shift.
            
364

    
    (66)  "Supportive personnel" means unlicensed individuals who:
            
365

    
    (a)  may assist a pharmacist, pharmacist preceptor, pharmacy intern, or licensed
            
366

    
pharmacy technician in nonjudgmental duties not included in the definition of the practice of
            
367

    
pharmacy, practice of a pharmacy intern, or practice of a licensed pharmacy technician, and as
            
368

    
those duties may be further defined by division rule adopted in collaboration with the board;

            
369


    
and
            
370

    
    (b)  are supervised by a pharmacist in accordance with rules adopted by the division in
            
371

    
collaboration with the board.
            
372

    
    (67)  "Unlawful conduct" is as defined in Sections 

58-1-501


 and 

58-17b-501


.
            
373

    
    (68)  "Unprofessional conduct" is as defined in Sections 

58-1-501


 and 

58-17b-502


 and
            
374

    
may be further defined by rule.
            
375

    
    (69)  "Veterinary pharmaceutical facility" means a pharmaceutical facility that
            
376

    
dispenses drugs intended for use by animals or for sale to veterinarians for the administration
            
377

    
for animals.
            
378

    
    Section 2.   Effective date.
            
379

    
    This bill takes effect on July 1, 2014.




 Legislative Review Note
    as of   2-4-14  12:43 PM

 Office of Legislative Research and General Counsel
[Bill Documents][Bills Directory]









Who represents me?





Remember my Legislators





State Senate
		350 North State, Suite 320
		PO Box 145115
		Salt Lake City, Utah 84114

		Telephone: (801) 538-1035
		Fax: (801) 326-1475



House of Representatives
		350 North State, Suite 350
		PO Box 145030
		Salt Lake City, Utah 84114

		Telephone: (801) 538-1029
		Fax: (801) 326-1544










Home
Mobile Site
Site Map
Calendar
Code / Constitution
House
Senate

Terms of Use/Privacy Policy

ADA
Utah.gov







